Study of ASN003 in Subjects With Advanced Solid Tumors

NCT02961283 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped reformulation

Conditions

Neoplasms
Melanoma
Colorectal Neoplasm
Carcinoma, Non-small Cell Lung

Interventions

DRUG: ASN003 ascending doses
DRUG: ASN003 MTD

Sponsor

Asana BioSciences